Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients

NCT00987415 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00987415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00987415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
June 30, 2014
Enrollment
253 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

elevated serum uric acid, heart failure